All three major indices are trading down today with the

Dow Jones Industrial Average

(

^DJI

) trading down 78 points (-0.5%) at 16,015 as of Monday, Jan. 25, 2016, 11:55 AM ET. The NYSE advances/declines ratio sits at 648 issues advancing vs. 2,316 declining with 132 unchanged.

The Health Services industry currently sits down 0.1% versus the S&P 500, which is down 0.6%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3.

Edwards Lifesciences

(

EW

) is one of the companies pushing the Health Services industry higher today. As of noon trading, Edwards Lifesciences is up $1.31 (1.7%) to $80.15 on light volume. Thus far, 361,067 shares of Edwards Lifesciences exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $79.08-$80.22 after having opened the day at $79.10 as compared to the previous trading day's close of $78.84.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. Edwards Lifesciences has a market cap of $16.8 billion and is part of the health care sector. Shares are down 0.2% year-to-date as of the close of trading on Friday. Currently there are 14 analysts who rate Edwards Lifesciences a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates

Edwards Lifesciences

as a

buy

. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full

Edwards Lifesciences Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading,

Stryker Corporation

(

SYK

) is up $0.68 (0.7%) to $94.59 on light volume. Thus far, 581,631 shares of Stryker Corporation exchanged hands as compared to its average daily volume of 1.6 million shares. The stock has ranged in price between $93.41-$94.60 after having opened the day at $93.41 as compared to the previous trading day's close of $93.91.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Stryker Corporation, together with its subsidiaries, operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. Stryker Corporation has a market cap of $34.5 billion and is part of the health care sector. Shares are up 1.0% year-to-date as of the close of trading on Friday. Currently there are 14 analysts who rate Stryker Corporation a buy, 2 analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates

TheStreet Recommends

Stryker Corporation

as a

buy

. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity and expanding profit margins. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Stryker Corporation Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading,

Becton Dickinson

(

BDX

) is up $1.80 (1.2%) to $146.56 on light volume. Thus far, 368,111 shares of Becton Dickinson exchanged hands as compared to its average daily volume of 1.1 million shares. The stock has ranged in price between $144.92-$146.56 after having opened the day at $145.12 as compared to the previous trading day's close of $144.76.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Becton, Dickinson and Company develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. Becton Dickinson has a market cap of $30.1 billion and is part of the health care sector. Shares are down 6.0% year-to-date as of the close of trading on Friday. Currently there are 9 analysts who rate Becton Dickinson a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates

Becton Dickinson

as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations, expanding profit margins, reasonable valuation levels and relatively strong performance when compared with the S&P 500 during the past year. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full

Becton Dickinson Ratings Report

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care

(

RXD

).